Company / Cash & Equivalents
SANUWAVE Health, Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$12.0M
FY2025
5-year range
$619.0K / $12.0M
FY2021-FY2025
Trend
+16.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has increased for 4 consecutive years, from $619,000 in FY2021 to $12M in FY2025.
Based on SEC 10-K filings.
$12M in FY2025 with a 5-year CAGR of +37.5%.
Improved from $2M to $12M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +118.1%
- 5-Year CAGR
- +37.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- SANUWAVE Health, Inc.'s cash & equivalents has grown for 4 consecutive years.
- 5-year CAGR of +37.5%, indicating consistent growth.
- In FY2025, cash & equivalents increased 16.8% year-over-year.
- Lowest cash & equivalents in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.0M | +16.8% |
| FY2024 | $10.2M | +469.7% |
| FY2023 | $1.8M | +55.9% |
| FY2022 | $1.2M | +86.3% |
| FY2021 | $619.0K | -74.6% |
| FY2020 | $2.4M | +568.5% |
| FY2019 | $364.5K | -50.1% |
| FY2018 | $730.2K | +446.7% |
| FY2017 | $133.6K | -12.7% |
| FY2016 | $152.9K | -95.7% |
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026